BlackBerry (BBRY) CEO Chen Compares Himself to Steve Jobs (AAPL)
Get Alerts BBRY Hot Sheet
Join SI Premium – FREE
BlackBerry (Nasdaq: BBRY) CEO John Chen has a lot on his plate and has been refreshingly down to earth about his company's chances to complete a turnaround.
Chen did an interview with the New York Times late last week. In part, the executive compared himself to the late Apple (Nasdaq: AAPL) co-founder Steve Jobs:
While Chen might have the best of intentions, comparing himself to Steve Jobs might be a little stretch. The company is now going after government and enterprise contracts, a much more difficult series of environments to gain a foothold in given different requirements and higher-standards necessary to meet security and performance measures.
Still, BlackBerry isn't starting from scratch, but it might need to become a little more innovative if its wants to make a dent it is target market.
Shares of BlackBerry are down 0.1 percent.
Chen did an interview with the New York Times late last week. In part, the executive compared himself to the late Apple (Nasdaq: AAPL) co-founder Steve Jobs:
I watched Steve Jobs on YouTube, when he came back to Apple ... He got up and said, ‘I don’t have a new product, I’m insanely focused on my customer base.’ That’s me now.
While Chen might have the best of intentions, comparing himself to Steve Jobs might be a little stretch. The company is now going after government and enterprise contracts, a much more difficult series of environments to gain a foothold in given different requirements and higher-standards necessary to meet security and performance measures.
Still, BlackBerry isn't starting from scratch, but it might need to become a little more innovative if its wants to make a dent it is target market.
Shares of BlackBerry are down 0.1 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canadian Solar (CSIQ) Comments on Complaint Filed by Maxeon Solar
- Boeing (BA) CEO to step down as plane maker undergoes management reshuffle
- Aldeyra Therapeutics (ALDX) Lays Out Clinical Development Plan for Resubmission of NDA for Reproxalap in Dry Eye Disease
Create E-mail Alert Related Categories
Insiders' Blog, Management CommentsRelated Entities
Steve JobsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!